Sector News

Axiall board rejects Westlake's $2.9-billion bid

February 1, 2016
Chemical Value Chain

Westlake Chemical (Houston) says its $2.9-billion bid to acquire Axiall (Atlanta) has been “summarily rejected” by the Axiall board of directors.

The combination would create North America’s second-largest producer of polyvinyl chloride (PVC), with 23% of the market’s 8.9 million m.t./year of production capacity.

“Axiall has rejected the proposal and refused to engage with us to discuss its merits,” says Albert Chao, Westlake’s president and CEO. “Instead, Axiall said it prefers to pursue a standalone strategic plan, but the market reaction to this plan does not suggest it will deliver anywhere near the value and upside of our proposal.”

Westlake offered $20 for each share of Axiall—$11 in cash and $9 in Westlake stock, for a 108% premium over Axiall’s closing price of $9.60/share on 22 January, the last trading day before the initial proposal. The deal included the assumption of liabilities, including $1.5 million of outstanding debt.

“In this challenging environment, we believe Axiall’s unwillingness to even discuss our compelling proposal exposes its shareholders to significant risk and uncertainty,” Chao says. “We urge the Axiall board to act in the best interests of its shareholders by meeting with us to begin negotiating a transaction without delay.”

Hassan Ahmed, analyst at Alembic Global Research, has issued a note arguing that Westlake’s initial offer significantly undervalues Axiall.

North America’s other producers of PVC include Shintech, the largest producer, followed by OxyChem, Formosa Plastics, and Mexichem.

The trading of Axiall closed Thursday at $9.79/share, down 1 ct for the day.

By Clay Boswell

Source: Chemical Week

Related News

February 28, 2021

Borealis to invest in new RTO to reduce CO2 emissions at Porvoo polyolefins plant

Chemical Value Chain

This equipment will significantly lower the site’s CO2 emissions, reduce flaring and save around 60 gigawatt hours (GWh) energy each year. Project kick-off is in February 2021, with completion planned for 2023.

February 28, 2021

Grace to acquire Albemarle’s fine chemistry business for $570 million

Chemical Value Chain

The acquisition significantly strengthens and expands Grace’s existing pharma portfolio. Pharma & Consumer is the largest, fastest growing and most profitable subsegment within Grace’s Materials Technologies business.

February 28, 2021

Solvay to carve out soda ash business

Chemical Value Chain

Solvay says it has decided to organize its soda ash and derivatives business into a separate and fully controlled legal structure.

Send this to a friend